Arkolith/Insider Trading/MEIP/Form 4

Baltic Charles V. III

DirectorMEI Pharma, Inc. (MEIP) · full profile →Form 4 · filed Mar 1, 2023
Net Buying
Open-Market Buys
$19K
Open-Market Sells
$0
Net Open-Market Flow
$19K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 28, 2023Buy(P)82K$0.23$19K106K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-014244) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML